79 related articles for article (PubMed ID: 24762501)
21. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?
Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
J Am Coll Surg; 2009 Jan; 208(1):87-95. PubMed ID: 19228509
[TBL] [Abstract][Full Text] [Related]
22. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
[TBL] [Abstract][Full Text] [Related]
23. Examining the accuracy and clinical usefulness of intraoperative frozen section analysis in the management of pancreatic lesions.
Nelson DW; Blanchard TH; Causey MW; Homann JF; Brown TA
Am J Surg; 2013 May; 205(5):613-7; discussion 617. PubMed ID: 23592172
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma of the pancreas and papilla of Vater--assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients.
Bakkevold KE; Arnesjø B; Kambestad B
Eur J Surg Oncol; 1992 Oct; 18(5):494-507. PubMed ID: 1426302
[TBL] [Abstract][Full Text] [Related]
25. Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head.
Prenzel KL; Hölscher AH; Vallböhmer D; Drebber U; Gutschow CA; Mönig SP; Stippel DL
Eur J Surg Oncol; 2010 Oct; 36(10):993-6. PubMed ID: 20594789
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
27. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y
Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266
[TBL] [Abstract][Full Text] [Related]
29. Relationship between nuclear morphometry, DNA content and resectability of pancreatic cancer.
He YC; Peng W; Qiao JG; Cao J; Chen JW
World J Gastroenterol; 2003 Aug; 9(8):1863-5. PubMed ID: 12918140
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.
Chao C; Hoffman JP; Ross EA; Torosian MH; Eisenberg BL
Am Surg; 2000 Apr; 66(4):378-85; discussion 386. PubMed ID: 10776876
[TBL] [Abstract][Full Text] [Related]
31. Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma?
Schmidt J; Fraunhofer S; Fleisch M; Zirngibl H
Hepatogastroenterology; 2004; 51(60):1827-31. PubMed ID: 15532836
[TBL] [Abstract][Full Text] [Related]
32. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma.
Lu CD; Morita S; Ishibashi T; Hara H; Isozaki H; Tanigawa N
Cancer; 1999 Mar; 85(6):1250-60. PubMed ID: 10189129
[TBL] [Abstract][Full Text] [Related]
33. Pain as a predictor of outcome in patients with operable pancreatic carcinoma.
Kelsen DP; Portenoy R; Thaler H; Tao Y; Brennan M
Surgery; 1997 Jul; 122(1):53-9. PubMed ID: 9225915
[TBL] [Abstract][Full Text] [Related]
34. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
35. Clinical predictors of resectability of pancreatic adenocarcinoma.
Almadi MA; Alharbi O; Azzam N; Altayeb M; Javed M; Alsaif F; Hassanain M; Alsharabi A; Al-Saleh K; Aljebreen AM
Saudi J Gastroenterol; 2013; 19(6):278-85. PubMed ID: 24195982
[TBL] [Abstract][Full Text] [Related]
36. Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography.
Choi MH; Yoon SB; Song M; Lee IS; Hong TH; Lee MA; Jung ES
PLoS One; 2020; 15(10):e0240318. PubMed ID: 33027288
[TBL] [Abstract][Full Text] [Related]
37. Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis.
Benke M; Farkas N; Hegyi P; Tinusz B; Sarlós P; Erőss B; Szemes K; Vörhendi N; Szakács Z; Szücs Á
Pathol Oncol Res; 2022; 28():1610266. PubMed ID: 35645620
[No Abstract] [Full Text] [Related]
38. Comparison of CT and angiography in assessing resectability of pancreatic carcinoma.
Jafri SZ; Aisen AM; Glazer GM; Weiss CA
AJR Am J Roentgenol; 1984 Mar; 142(3):525-9. PubMed ID: 6607638
[TBL] [Abstract][Full Text] [Related]
39. Use of volumetric CT scanning to predict tumor staging and survival in pancreatic cancer patients that are to be administered curative resection.
Sengul Samanci N; Çelik E; Bagcilar O; Tutar O; Samanci C; Velidedeoglu M; Yassa AE; Demirci NS; Demirelli FH
J Surg Oncol; 2021 May; 123(8):1757-1763. PubMed ID: 33684252
[TBL] [Abstract][Full Text] [Related]
40. Color flow sonography in evaluating the resectability of periampullary and pancreatic tumors.
Ralls PW; Wren SM; Radin R; Stain SC; Yang J; Parekh D
J Ultrasound Med; 1997 Feb; 16(2):131-40. PubMed ID: 9166806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
